Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M De Wit, A Kavanaugh… - Nature Reviews …, 2016 - nature.com
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M de Wit, A Kavanaugh… - Nature Reviews …, 2016 - go.gale.com
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.
L Gossec, LC Coates, M de Wit… - Nature reviews …, 2016 - europepmc.org
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M de Wit… - Nature reviews …, 2016 - pubmed.ncbi.nlm.nih.gov
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
[引用][C] Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M de Wit… - Nature Reviews …, 2016 - providence.elsevierpure.com
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA
recommendations — Providence Skip to main navigation Skip to search Skip to main content …
recommendations — Providence Skip to main navigation Skip to search Skip to main content …
[PDF][PDF] Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M de Wit, A Kavanaugh… - 2016 - researchgate.net
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
[PDF][PDF] Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M de Wit, A Kavanaugh… - cmeoutfitters.com
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M De Wit… - Nature Reviews …, 2016 - search.proquest.com
Psoriatic arthritis (PsA) is a heterogeneous, potentially severe disease. Many therapeutic
agents are now available for PsA, but treatment decisions are not always straightforward. To …
agents are now available for PsA, but treatment decisions are not always straightforward. To …
[引用][C] Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
L Gossec, LC Coates, M Wit… - Nature …, 2016 - scholarlypublications …
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA
recommendations | Scholarly Publications Skip to main content Universiteit Leiden Leiden …
recommendations | Scholarly Publications Skip to main content Universiteit Leiden Leiden …